Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 9/20 | 0.48 |
| ▸ | CA2 known ✓ | P00918 | 9/20 | 0.48 |
| ▸ | CA12 known ✓ | O43570 | 3/20 | 0.48 |
| ▸ | CA4 known ✓ | P22748 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.79 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.79 |
| ▸ | GLA | P06280 | 1/20 | 0.79 |
| ▸ | HPGD | P15428 | 1/20 | 0.79 |
| ▸ | TSHR | P16473 | 1/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.79 |
| ▸ | BLM | P54132 | 1/20 | 0.79 |
| ▸ | CA9 | Q16790 | 8/20 | 0.48 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | CA3 | P07451 | 2/20 | 0.48 |
| ▸ | CA6 | P23280 | 2/20 | 0.48 |
| ▸ | CA5A | P35218 | 2/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleyl Sulfate SCHEMBL66443 | 1.00 | RECQL (0.79) | RECQLEPHX2GLAHPGDTSHR | |
| SCHEMBL4938997 | 1.00 | RECQL (0.79) | RECQLEPHX2GLAHPGDTSHR | |
| Oleyl Sulfate SCHEMBL28285638 | 1.00 | RECQL (0.79) | RECQLEPHX2GLAHPGDTSHR | |
| Oleyl Sulfate SCHEMBL17748276 | 1.00 | RECQL (0.79) | RECQLEPHX2GLAHPGDTSHR | |
| Oleyl Sulfate SCHEMBL31214624 | 1.00 | RECQL (0.79) | RECQLEPHX2GLAHPGDTSHR | |
| SCHEMBL31399244 | 1.00 | RECQL (0.79) | RECQLEPHX2GLAHPGDTSHR | |
| Oleyl Sulfate SCHEMBL66441 | 1.00 | RECQL (0.79) | RECQLEPHX2GLAHPGDTSHR | |
| SCHEMBL11586891 | 1.00 | RECQL (0.79) | RECQLEPHX2GLAHPGDTSHR | |
| Oleyl Sulfate SCHEMBL29367725 | 1.00 | RECQL (0.79) | RECQLEPHX2GLAHPGDTSHR | |
| Oleyl Sulfate SCHEMBL6114243 | 0.98 | RECQL (0.76) | RECQLEPHX2GLAHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704798-A1 | THERAPEUTIC AND NON-THERAPEUTIC USES OF A PERSONAL CLEANSING COMPOSITION AND METHODS OF TREATEMENT | The Procter & Gamble Company (US) | 2026-03-11 | — | — | EP | claimed |
| US-20250009627-A1 | THERAPEUTIC AND NON-THERAPEUTIC USES OF A PERSONAL CLEANSING COMPOSITION AND METHODS OF TREATMENT | THE PROCTER & GAMBLE COMPANY | 2025-01-09 | — | — | US | claimed |
| WO-2025006194-A1 | THERAPEUTIC AND NON-THERAPEUTIC USES OF A PERSONAL CLEANSING COMPOSITION AND METHODS OF TREATEMENT | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-02 | — | — | WO | claimed |
| EP-4704798-A1 | THERAPEUTIC AND NON-THERAPEUTIC USES OF A PERSONAL CLEANSING COMPOSITION AND METHODS OF TREATEMENT | The Procter & Gamble Company (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20250009627-A1 | THERAPEUTIC AND NON-THERAPEUTIC USES OF A PERSONAL CLEANSING COMPOSITION AND METHODS OF TREATMENT | THE PROCTER & GAMBLE COMPANY | 2025-01-09 | — | — | US | disclosed |
| WO-2025006194-A1 | THERAPEUTIC AND NON-THERAPEUTIC USES OF A PERSONAL CLEANSING COMPOSITION AND METHODS OF TREATEMENT | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009627-A1 | THERAPEUTIC AND NON-THERAPEUTIC USES OF A PERSONAL CLEANSING COMPOSITION AND METHODS OF TREATMENT | CUTA, NOTUM, SPOUT1 | CA1 4625/4885CA2 3546/4885CA12 2535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.